When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic
- PMID: 32532460
- PMCID: PMC7275160
- DOI: 10.1016/j.ygyno.2020.06.001
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic
Abstract
The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing elective surgical procedures and proceeding cautiously with cancer procedures that may require significant hospital resources and expose vulnerable patients to the virus. These challenges have particularly distressing for women with a gynecologic cancer diagnosis and their providers. Currently, circumstances vary greatly by region and by hospital, depending on COVID-19 prevalence, case mix, hospital type, and available resources. Therefore, COVID-19-related modifications to surgical practice guidelines must be individualized. Special consideration is necessary to evaluate the appropriateness of procedural interventions, recognizing the significant resources and personnel they require. Additionally, the pandemic may occur in waves, with patient demand for surgery ebbing and flowing accordingly. Hospitals, cancer centers and providers must prepare themselves to meet this demand. The purpose of this white paper is to highlight all phases of gynecologic cancer surgical care during the COVID-19 pandemic and to illustrate when it is best to operate, to hestitate, and reintegrate surgery. Triage and prioritization of surgical cases, preoperative COVID-19 testing, peri-operative safety principles, and preparations for the post-COVID-19 peak and surgical reintegration are reviewed.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr. Warner Huh reports personal fees from LICOR, outside the submitted work and Expert Witness: Skadden (on behalf of Intuitive Surgical). Dr. Bhavana Pothuri reports grants, personal fees and non-financial support outside the submitted work; institutional PI for industry sponsored trials from Tesaro/GSK, AstraZeneca, Merck, Genentech/Roche, and Clovis Oncology. Compensated advisory boards include Tesaro/GSK, AstraZeneca, and Eisai. Dr. Mario Leitao reports personal fees from JnJ/Ethicon, outside the submitted work and Dr. Leitao is an ad hoc speaker for Intuitive Surgical, Inc. Dr. Joshua Kesterson reports personal fees from GSK/Tesaro, personal fees from Clovis Oncology, outside the submitted work. Dr. Jason Wright reports grants from Merck, personal fees from Clovis Oncology, outside the submitted work. Dr. Amer Karam reports personal fees from Clovis Oncology, personal fees from GSK, personal fees from Astra Zeneca, personal fees from UpToDate, outside the submitted work. Dr. S. Diane Yamada reports other from LEAP Therapeutics, outside the submitted work. All other authors have nothing to disclose.
Similar articles
-
Management of patients with ovarian cancer in the COVID-19 era.J Surg Oncol. 2020 Aug;122(2):122-123. doi: 10.1002/jso.26057. Epub 2020 May 31. J Surg Oncol. 2020. PMID: 32476155 Free PMC article.
-
Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.Oral Oncol. 2020 Aug;107:104813. doi: 10.1016/j.oraloncology.2020.104813. Epub 2020 May 21. Oral Oncol. 2020. PMID: 32471801 Free PMC article.
-
Head and neck cancer surgery in COVID-19 pandemic in Northern Italy.Oral Oncol. 2020 Aug;107:104835. doi: 10.1016/j.oraloncology.2020.104835. Epub 2020 May 30. Oral Oncol. 2020. PMID: 32505553 Free PMC article.
-
International Society for Gynecologic Endoscopy (ISGE) guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the SARS-CoV-2 pandemic.Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:133-140. doi: 10.1016/j.ejogrb.2020.08.039. Epub 2020 Aug 26. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32866856 Free PMC article. Review.
-
Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society.Fetal Diagn Ther. 2020;47(9):689-698. doi: 10.1159/000508254. Epub 2020 May 6. Fetal Diagn Ther. 2020. PMID: 32375144 Free PMC article. Review.
Cited by
-
Practical Recommendations for the Preoperative Screening and Protective Protocols in Cancer Surgeries During COVID-19: A Systematic Review.Front Surg. 2021 Nov 23;8:678700. doi: 10.3389/fsurg.2021.678700. eCollection 2021. Front Surg. 2021. PMID: 34901132 Free PMC article.
-
Promoting health equity in the era of COVID-19.Gynecol Oncol. 2020 Jul;158(1):25-31. doi: 10.1016/j.ygyno.2020.05.023. Epub 2020 May 19. Gynecol Oncol. 2020. PMID: 32446719 Free PMC article. No abstract available.
-
Gynecologic Surgery during the COVID-19 Pandemic: Is Universal Screening Mandatory?Infect Dis Obstet Gynecol. 2021 Aug 23;2021:5528334. doi: 10.1155/2021/5528334. eCollection 2021. Infect Dis Obstet Gynecol. 2021. PMID: 34471341 Free PMC article.
-
Perioperative SARS-CoV-2 infection among women undergoing major gynecologic cancer surgery in the COVID-19 era: A nationwide, cohort study from Turkey.Gynecol Oncol. 2021 Feb;160(2):499-505. doi: 10.1016/j.ygyno.2020.11.014. Epub 2020 Nov 17. Gynecol Oncol. 2021. PMID: 33223221 Free PMC article.
-
Recommendations for the safety of hospitalised patients in the context of the COVID-19 pandemic: a scoping review.BMJ Open. 2022 Sep 19;12(9):e060182. doi: 10.1136/bmjopen-2021-060182. BMJ Open. 2022. PMID: 36123068 Free PMC article.
References
-
- World Health Organization Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at...
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical